Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-Machi, Aoba-ku, Sendai, Japan.
Department of Applied Information Sciences, Graduate School of Information Sciences, Tohoku University, 6-6-05 Aramaki Aza Aoba, Aoba-ku, Sendai, Japan.
J Biochem. 2019 Feb 1;165(2):139-158. doi: 10.1093/jb/mvy096.
Personalized healthcare (PHC) based on an individual's genetic make-up is one of the most advanced, yet feasible, forms of medical care. The Tohoku Medical Megabank (TMM) Project aims to combine population genomics, medical genetics and prospective cohort studies to develop a critical infrastructure for the establishment of PHC. To date, a TMM CommCohort (adult general population) and a TMM BirThree Cohort (birth+three-generation families) have conducted recruitments and baseline surveys. Genome analyses as part of the TMM Project will aid in the development of a high-fidelity whole-genome Japanese reference panel, in designing custom single-nucleotide polymorphism (SNP) arrays specific to Japanese, and in estimation of the biological significance of genetic variations through linked investigations of the cohorts. Whole-genome sequencing from >3,500 unrelated Japanese and establishment of a Japanese reference genome sequence from long-read data have been done. We next aim to obtain genotype data for all TMM cohort participants (>150,000) using our custom SNP arrays. These data will help identify disease-associated genomic signatures in the Japanese population, while genomic data from TMM BirThree Cohort participants will be used to improve the reference genome panel. Follow-up of the cohort participants will allow us to test the genetic markers and, consequently, contribute to the realization of PHC.
基于个体基因构成的个性化医疗(PHC)是最先进、最可行的医疗形式之一。东北医疗巨量数据库(Tohoku Medical Megabank,TMM)项目旨在结合人群基因组学、医学遗传学和前瞻性队列研究,为 PHC 的建立开发关键基础设施。迄今为止,TMM CommCohort(成年普通人群)和 TMM BirThree Cohort(出生+三代家庭)已经进行了招募和基线调查。作为 TMM 项目的一部分,基因组分析将有助于开发高保真全基因组日本参考面板,设计针对日本人的定制单核苷酸多态性(SNP)阵列,并通过对队列的连锁研究来估计遗传变异的生物学意义。已经对超过 3500 名无关的日本人进行了全基因组测序,并从长读数据中建立了日本参考基因组序列。接下来,我们的目标是使用我们的定制 SNP 阵列获得所有 TMM 队列参与者(超过 150000 人)的基因型数据。这些数据将有助于确定日本人群中与疾病相关的基因组特征,而 TMM BirThree Cohort 参与者的基因组数据将用于改进参考基因组面板。对队列参与者的随访将使我们能够测试遗传标记,并因此为实现 PHC 做出贡献。